Analyst Ratings January 29, 2026

Truist Sticks With Buy on Microsoft, Cites Strong Commercial Demand Despite Azure Constraints

Analyst sees multi-pronged growth from Commercial Cloud, Copilot and AI platforms while acknowledging supply limits and higher capex

By Nina Shah MSFT
Truist Sticks With Buy on Microsoft, Cites Strong Commercial Demand Despite Azure Constraints
MSFT

Truist Securities reaffirmed a Buy rating and set a $675 price target on Microsoft, pointing to robust commercial bookings, large commercial RPO and several AI-driven growth vectors even as Azure growth remains supply-constrained and capital spending is elevated. Recent quarterly results beat expectations on both EPS and revenue, while Raymond James trimmed its price target but kept an Outperform rating.

Key Points

  • Truist reaffirmed Buy on Microsoft with a $675 price target, citing strong commercial bookings and a $625 billion commercial RPO.
  • Microsoft beat fiscal Q2 2026 estimates with EPS of $4.14 and revenue of $81.3 billion, supporting the firm’s view of durable demand.
  • Valuation metrics show a high earnings multiple - P/E of 34.12 and PEG of 2.11 - while Truist still views Microsoft as a top-tier long-term compounder; impacted sectors include cloud services, enterprise software and AI platforms.

Truist Securities has reiterated a Buy rating on Microsoft Corporation (NASDAQ:MSFT), preserving a price target of $675.00. The firm cites persistent strength in commercial demand as the primary rationale for the recommendation, even as investors scrutinize Azure growth rates and the company’s elevated capital expenditure levels.

According to InvestingPro data referenced by Truist, Microsoft was trading at a price of $481.63 at the time the firm set its target, which Truist frames as implying roughly a 40% upside to its $675 target. InvestingPro also shows Microsoft trading at a price-to-earnings ratio of 34.12, a metric Truist notes is consistent with the assessment that the company is trading at a high earnings multiple.

Truist highlighted the company’s second-quarter commercial performance as evidence of durable demand. Bookings rose by more than 230% year-over-year, the firm said, and commercial remaining performance obligation - or commercial RPO - reached $625 billion. Those metrics, Truist argues, demonstrate broad-based demand across Microsoft’s customer base and support the company’s revenue momentum.

The firm pointed to Microsoft’s trailing revenue of $293.81 billion, which represents a 15.59% increase over the last twelve months. Truist described Microsoft as a "top tier, long-term compounder" with multiple growth vectors, including Commercial Cloud, Microsoft 365 Copilot, AI platforms and agentic capabilities.

On Azure specifically, Truist acknowledged that growth remains supply-constrained. Management has reiterated that demand outstrips available capacity and that the limited capacity is being allocated across first-party AI products, research and development, and Azure itself. The firm emphasized that these allocation choices reflect how management is prioritizing resources amid strong demand.

Truist also assessed Microsoft’s underlying fundamentals as "strong beneath the surface," even as market participants reacted to the reported Azure growth rates and higher capital expenditures disclosed in the company’s recent quarterly results. InvestingPro’s analysis places Microsoft near its Fair Value and reports a PEG ratio of 2.11, which the platform interprets as indicative of a high P/E ratio relative to near-term earnings growth.

On the earnings front, Microsoft reported fiscal second-quarter 2026 results that exceeded analyst forecasts. The company posted earnings per share of $4.14, topping the consensus estimate of $3.93. Revenue for the quarter reached $81.3 billion, versus an expected $80.23 billion.

In related analyst activity, Raymond James reduced its price target for Microsoft to $580 from $600 but kept an Outperform rating in place. Raymond James noted that Azure’s growth and the company’s guidance were slightly below investor expectations, a factor reflected in the lowered target.

Investors and analysts looking for deeper, model-based context can consult Microsoft’s Pro Research Report on InvestingPro, one of more than 1,400 reports available on the platform. The InvestingPro data cited by Truist is used to underline valuation measures and comparative metrics referenced in the firm’s analysis.


What this means

  • Truist’s reiteration of a Buy rating underscores confidence in Microsoft’s commercial demand and long-term growth avenues despite near-term headwinds.
  • Key growth areas identified by the firm include Commercial Cloud offerings, Microsoft 365 Copilot, AI platforms and agentic capabilities, all of which underpin its long-term compounder thesis.

Market signals and valuation observations

  • InvestingPro data places Microsoft at a P/E of 34.12 and a PEG of 2.11, metrics that the platform and Truist interpret as showing the company is trading at a relatively high earnings multiple compared with near-term growth expectations.
  • Despite the high multiple, Truist’s $675 target implies a significant upside versus the cited market price of $481.63.

Risks

  • Azure growth remains supply-constrained, with management allocating limited capacity among first-party AI products, R&D and Azure - a constraint that affects cloud infrastructure providers and enterprise customers.
  • Elevated capital expenditures reported in the quarterly results could weigh on near-term investor sentiment and earnings metrics, impacting technology and capital-intensive segments.
  • Azure growth and guidance were noted as slightly below investor expectations by Raymond James, introducing uncertainty for near-term revenue momentum in cloud services.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026